Natera wins $19 million US verdict from ArcherDX in cancer-detection patent case

By Blake Brittain (Reuters) – Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it $19.3 million in damages from Invitae Corp’s ArcherDX for infringing patents related to cancer detection. The jury agreed with Natera that biotech company ArcherDX Inc’s blood-based DNA tests for detecting and monitoring cancer infringed three…

Read More

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

By Jennifer Rigby LONDON (Reuters) – New highly-effective weight loss drugs such as Novo Nordisk’s Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.    The…

Read More